home / stock / psnl / psnl news


PSNL News and Press, Personalis Inc. From 12/09/20

Stock Information

Company Name: Personalis Inc.
Stock Symbol: PSNL
Market: NASDAQ
Website: personalis.com

Menu

PSNL PSNL Quote PSNL Short PSNL News PSNL Articles PSNL Message Board
Get PSNL Alerts

News, Short Squeeze, Breakout and More Instantly...

PSNL - Personalis Announces Delivery of the 100,000th Genome to the U.S. Department of Veterans Affairs Million Veteran Program

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, announced today that it has delivered the 100,000th whole human genome sequence dataset to the U.S. Department of Veterans Affairs Million Veteran Program (VA MVP). Although Personalis h...

PSNL - Personalis: Still Going Strong

Despite Covid-19, Personalis has seen a big jump in its share price while underlying achievements are held back by the virus. I liked the appeal of the business and anecdotal improvements earlier this year (orders) as current numbers do not reflect the real progress being made. Af...

PSNL - Personalis, Inc. to Present at EACR Liquid Biopsies Virtual Event

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced that the company will participate in the EACR Liquid Biopsies Virtual Event, November 18-19, including a poster presentation and satellite symposia. The company will ...

PSNL - Liquid Biopsy Cancer Testing Is The Next Big Investment Opportunity

Multiple companies are working on next-gen blood biopsies tech to detect cancer. The potential market size is big according to most estimates and analysts. Mergers and acquisitions seem to suggest that the era of liquid biopsies has arrived. The frontrunners highlighted in the...

PSNL - Personalis® to Present at the AMP Annual Meeting 2020

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that the company will present data from its clinical test - NeXT Dx TM - at the virtual AMP Annual Meeting from Nov 16-20, 2020. The poster presentation, titled “An exome and transc...

PSNL - Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today announced that the company will participate in the Society for Immunotherapy of Cancer (SITC) Annual Meeting online, November 11-14, including poster presentations on November 11 ...

PSNL - Personalis' (PSNL) CEO John West on Q3 2020 Results - Earnings Call Transcript

Personalis, Inc. (PSNL) Q3 2020 Earnings Conference Call November 5, 2020 5:00 PM ET Company Participants Caroline Corner – Investor Relations John West – President and Chief Executive Officer Aaron Tachibana – Chief Financial Officer Conference Call Participants Ivy X. M...

PSNL - Personalis EPS beats by $0.01, beats on revenue

Personalis (PSNL): Q3 GAAP EPS of -$0.27 beats by $0.01.Revenue of $19.8M (+15.5% Y/Y) beats by $0.74M.Shares -4.2% AH.Press Release For further details see: Personalis EPS beats by $0.01, beats on revenue

PSNL - Personalis Reports Third Quarter 2020 Financial Results

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for population sequencing and cancer, today reported financial results for the third quarter ended September 30, 2020. Third Quarter Highlights Reported record revenues of $19.8 million in the third quarter of ...

PSNL - Biodesix prices IPO at $18/share, trades today

Lung cancer diagnostics company, Biodesix (BDSX) has priced initial public offering of ~4.17M common shares at $18/share.Underwriters' over-allotment is an additional 600K shares.Trading commences today on Nasdaq.Offering is expected to close on October 30.Net proceeds of ~$30M will be u...

Previous 10 Next 10